![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Direct Oral Anticoagulants Compared With Dalteparin for TX of Cancer-Associated Thrombosis (Mayo Proceedings) View |
![]() |
Edoxaban versus dalteparin for venous thromboembolism associated with cancer (ecancer) View |
![]() |
Rivaroxaban for thromboprophylaxis in high-risk cancer patients: CASSINI results (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
ASH 2017: Gary E. Raskob: Edoxaban vs. Dalteparin for VTE in Cancer: Hokusai VTE-Cancer Study (Oncoletter) View |
![]() |
DOAC VTE Prophylaxis for Patients with Cancer (Medication Quality and Safety Rx) View |
![]() |
Thromboprophylaxis Strategy in Cancer Outpatients (Thrombosis.TV) View |
![]() |
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients (Oncoletter) View |
![]() |
Cancer Associated Thrombosis (UHL Clinical Education) View |
![]() |
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE (American Society of Hematology) View |
![]() |
Rivaroxaban in Cancer-Associated VTE: Results from CALLISTO (American Society of Hematology) View |